Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune Response

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 4, 2007, Pages 412-422

  Badillo, Andrea T ^a   Beggs, Kirstin J ^a   Javazon, Elisabeth H ^a   Tebbets, Jessica C ^a   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Immune recognition; In vivo; Mesenchymal stem cells; Murine; Stromal progenitor cells

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; DONOR; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; SKIN GRAFT; SPLEEN; STROMA CELL;

ANIMALS; ANTIGENS, CD4; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; IMMUNE TOLERANCE; ISOANTIGENS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN TRANSPLANTATION; STROMAL CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947200410     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.12.447     Document Type: Article

References (50)

1. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
3. Javazon E.H., Beggs K.J., and Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32 (2004) 414-425
4. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
5. Angoulvant D., Clerc A., Benchalal S., et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 41 (2004) 469-476
6. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
7. Beyth S., Borovsky Z., Mevorach D., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214-2219
8. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
9. Jiang X.X., Zhang Y., Liu B., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120-4126
10. Krampera M., Glennie S., Dyson J., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003) 3722-3729
11. Le Blanc K., Rasmusson I., Gotherstrom C., et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60 (2004) 307-315
12. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., and Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (2003) 11-20
13. Maccario R., Podesta M., Moretta A., et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90 (2005) 516-525
14. Maitra B., Szekely E., Gjini K., et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33 (2004) 597-604
15. Majumdar M.K., Keane-Moore M., Buyaner D., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10 (2003) 228-241
16. Meisel R., Zibert A., Laryea M., et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
17. Rasmusson I., Ringden O., Sundberg B., and Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76 (2003) 1208-1213
18. Rasmusson I., Ringden O., Sundberg B., and Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305 (2005) 33-41
19. Glennie S., Soeiro I., Dyson P.J., Lam E.W., and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated t cells. Blood 105 (2005) 2821-2827
20. Bacigalupo A. Mesenchymal stem cells and haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 17 (2004) 387-399
21. Devine S.M., Peter S., Martin B.J., Barry F., and McIntosh K.R. Mesenchymal stem cells: stealth and suppression. Cancer J 7 Suppl 2 (2001) S76-S82
22. El-Badri N.S., Maheshwari A., and Sanberg P.R. Mesenchymal stem cells in autoimmune disease. Stem Cells Dev 13 (2004) 463-472
23. Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 6 (2004) 369-374
24. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5 (2003) 485-489
25. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
26. Le Blanc K., and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 321-334
27. Le Blanc K., and Ringden O. Use of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantation. Haematologica 90 (2005) 438a
28. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
29. Eliopoulos N., Stagg J., Lejeune L., Pommey S., and Galipeau J. Allogeneic marrow stromal cells are immune rejected by mhc class I- and class II-mismatched recipient mice. Blood 106 (2005) 4057-4065
30. Billingham R.E., and Medawar P.B. The technique of free skin grafting in mammals. J Exp Biol 28 (1951) 385-402
31. Potian J.A., Aviv H., Ponzio N.M., Harrison J.S., and Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171 (2003) 3426-3434
32. Guo Z., Li H., Li X., et al. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 24 (2006) 992-1000
33. Wu Q., Feng Y., Yang Y., et al. Kinetics of the phenotype and function of murine peritoneal macrophages following acute inflammation. Cell Mol Immunol 1 (2004) 57-62
34. Tolar J., O'Shaughnessy M.J., Panoskaltsis-Mortari A., et al. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood 107 (2006) 4182-4188
35. Kievits F., Boerenkamp W.J., and Ivanyi P. H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media. J Immunol 140 (1988) 4253-4255
36. MacDermott R.P., and Bragdon M.J. Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity. Behring Inst Mitt (1983) 122-128
37. Spees J.L., Gregory C.A., Singh H., et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9 (2004) 747-756
38. Bensidhoum M., Chapel A., Francois S., et al. Homing of in vitro expanded stro-1- or stro-1+ human mesenchymal stem cells into the nod/scid mouse and their role in supporting human CD34 cell engraftment. Blood 103 (2004) 3313-3319
39. Francois S., Bensidhoum M., Mouiseddine M., et al. Local irradiation induces not only homing of human mesenchymal stem cells (HMSC) at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution following irradiation damages. Stem Cells. 24 (2005) 1020-1029
40. Isakova I.A., Baker K., Dufour J., Gaupp D., and Phinney D.G. Preclinical evaluation of adult stem cell engraftment and toxicity in the cns of rhesus macaques. Mol Ther. 13 (2006) 1173-1184
41. Lu D., Li Y., Wang L., et al. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 18 (2001) 813-819
42. Noort W.A., Kruisselbrink A.B., in't Anker P.S., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in nod/scid mice. Exp Hematol 30 (2002) 870-878
43. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
44. Saito T., Kuang J.Q., Bittira B., Al-Khaldi A., and Chiu R.C. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74 (2002) 19-24 [discussion 24]
45. Niyibizi C., Wang S., Mi Z., and Robbins P.D. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol Ther 9 (2004) 955-963
46. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73 (2002) 1919-1925 [discussion 1926]
47. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
48. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by AKT-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
49. Mayer H., Bertram H., Lindenmaier W., et al. Vascular endothelial growth factor (vegf-a) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95 (2005) 827-839
50. Togel F., Hu Z., Weiss K., et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289 (2005) F31-F42